Stock Events

Stock Events

Albert Labs International 

C$0.005000
4
+C$0.00+0%Tuesday 20:00

Statistics

Day High
0.005
Day Low
0.005
52W High
0.005
52W Low
0.005
Volume
0
Avg. Volume
0
Mkt Cap
372,065
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-Profit Margin
Unprofitable
2017
2018
2019
2020
2021
2022
0Revenue
-7.06MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Compass Pathways
CMPS
Mkt Cap1.6B
Compass Pathways operates in the psychedelic medicine sector, focusing on psilocybin therapy for mental health issues, similar to Albert Labs' focus on psychedelic treatments.
GH Research
GHRS
Mkt Cap1.43B
GH Research is involved in the development of 5-MeO-DMT therapies for depression, aligning closely with Albert Labs' interest in psychedelic therapy for similar conditions.
AtaiBeckley
ATAI
Mkt Cap2.73B
ATAI Life Sciences works on biotech and psychedelic treatments for mental health disorders, overlapping with Albert Labs' research and development focus.
Nuveen Municipal Income
NUMI
Mkt Cap0
Numinus Wellness is involved in the development of psychedelic therapies, offering services that compete with Albert Labs' approach to mental health treatment.
Revive Therapeutics
RVVTF
Mkt Cap9.15M
Revive Therapeutics explores psychedelic medicines for various treatments, including mental health, a direct competition to Albert Labs' focus area.
Noveris Health Sciences
MYCOF
Mkt Cap42.74M
Mydecine Innovations Group focuses on developing and deploying psychedelic medicine, competing in the same therapeutic space as Albert Labs.

About

Albert Labs International Corp. is a pharmaceutical research and development company dedicated to addressing urgent and underserved patient needs, particularly in critical mental health. The firm specializes in creating psilocybin-assisted therapies aimed at improving conditions such as anxiety, depression, and the psychological distress linked to cancer. This enterprise operates out of Burnaby, Canada.
Show More
CEO
Navchand Jagpal
Country
Canada
ISIN
CA0127841041
WKN
000A3DJEF

Listings

CN
CA
ABRT.CN

0 Comments

Share your thoughts

FAQs

What is Albert Labs International stock price today?▼
The current price of ABRT.CN is C$0.01 CAD — it has increased by +0% in the past 24 hours. Watch Albert Labs International stock price performance more closely on the chart.
What is Albert Labs International stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Canadian Securities Exchange exchange Albert Labs International stocks are traded under the ticker ABRT.CN.
What is Albert Labs International market cap?▼
Today Albert Labs International has the market capitalization of 372,065
What is Albert Labs International revenue for the last year?▼
Albert Labs International revenue for the last year amounts to 0 CAD.
What is Albert Labs International net income for the last year?▼
ABRT.CN net income for the last year is -7.06M CAD.
In which sector is Albert Labs International located?▼
Albert Labs International operates in the Health & Wellness sector.
When did Albert Labs International complete a stock split?▼
The last stock split for Albert Labs International was on March 10, 2022 with a ratio of 1:10.
Where is Albert Labs International headquartered?▼
Albert Labs International is headquartered in Burnaby, Canada.